Nuclear medicine firm Digirad saw revenue growth in its 2014 third quarter and nine-month period (end-September 30).
The company posted revenues of $13.9 million for the quarter, up 12% from revenues of $12.4 million in the same period a year ago. Net income was $1.2 million, compared with net income of $2.5 million in the same quarter last year, Digirad said.
Nine-month revenues were $41.5 million, up 13% from revenues of $36.8 million in the same period in 2013. Net income was $1.7 million, compared with a net loss of $523,000 last year, according to the firm.
